Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal second quarter 2025 results through the filing of its Form 10-Q. Since our previous update, the company has made progress with its ...

KELOWNA, BC / ACCESS Newswire / May 12, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update on ...

Well, Pride Month is coming to a close, and so is this column. I wouldn’t be Dr. Lexx if I didn’t leave you with a little bit of education from a sex-positive and shame-free perspective.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Welcome to Better Sex With Dr. Lexx, a monthly column where sex therapist, educator and consultant Dr. Lexx Brown-James shares expertise, advice and wisdom about sex, relationships and more.

Get his next trade alert for free, right here. Lexaria Bioscience Corp LEXX shares are trading lower by 6.5% to $2.43 Thursday morning after the company finalized agreements for a registered ...

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...